Should FDA Slow Down Drug Approval in Oncology?

Should FDA Slow Down Drug Approval in Oncology? is organized by Rush University Medical Center.

Start Date: 1/19/22
End Date: 1/19/23

Activity Topic:
Pharmacy

Description:
Learn about the history and role of the FDA Accelerated Approval Program. The speaker will take you through the current trends and challenges of the drug approval process in oncology and investigate a potential solutions to the current oncological drug approval dilemma.